Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Pfizer Inc. | 37 | 4 | 10 | 0 | €25.62 | €40.00 | 56.128% |
| PTC Therapeutics Inc. | 16 | 9 | 2 | 1 | €28.80 | €41.81 | 45.188% |
| Agios Pharmaceuticals Inc. | 8 | 1 | 1 | 1 | €38.20 | €43.87 | 14.840% |
| AnaptysBio Inc | 8 | 1 | 0 | 0 | €23.40 | €45.21 | 93.205% |
| Rhythm Pharmaceuticals | 15 | 0 | 0 | 0 | €40.40 | €46.08 | 14.066% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €47.20 | €50.00 | 5.932% |
| Halozyme Therapeutics Inc. | 20 | 0 | 2 | 0 | €48.84 | €52.75 | 8.001% |
| Arrowhead Pharmaceuticals Inc. | 22 | 2 | 6 | 0 | €23.44 | €54.74 | 133.549% |
| Ionis Pharmaceuticals Inc. | 20 | 5 | 0 | 0 | €43.51 | €56.72 | 30.365% |
| Celldex Therapeutics | 15 | 1 | 3 | 0 | €33.60 | €58.01 | 72.651% |
| Viking Therapeutics Inc | 7 | 0 | 2 | 0 | €50.10 | €62.50 | 24.750% |
| Insmed Inc. | 40 | 1 | 11 | 1 | €64.50 | €70.63 | 9.508% |
| Exact Sciences | 20 | 0 | 6 | 0 | €40.77 | €74.22 | 82.078% |
| Gilead Sciences Inc | 23 | 1 | 12 | 0 | €62.65 | €75.00 | 19.713% |
| Incyte Corp. | 12 | 3 | 0 | 1 | €56.14 | €78.05 | 39.022% |
| Cytokinetics Inc. | 34 | 1 | 2 | 0 | €51.00 | €83.56 | 63.844% |
| Intra-Cellular Therapies Inc. | 35 | 0 | 10 | 0 | €68.50 | €84.40 | 23.215% |
| Ultragenyx Pharmaceutical Inc. | 22 | 1 | 1 | 0 | €37.40 | €85.51 | 128.640% |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €75.16 | €100.00 | 33.049% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 1 | 0 | €76.76 | €103.66 | 35.042% |
| Abbott Laboratories | 21 | 0 | 3 | 0 | €93.98 | €115.05 | 22.420% |
| Merck & Co. Inc. | 35 | 1 | 6 | 0 | €116.60 | €125.02 | 7.219% |